At hyperCORE, collaboration and innovation are at the heart of everything we do. We are proud to announce our selection as one of the top six global site networks invited to join a strategic industry advisory group—a distinguished forum uniting industry-leading site networks worldwide to advance the future of clinical research.

Together with the other elite members, hyperCORE will contribute to initiatives designed to maximize commercial study opportunities, expand access to novel therapies, and improve health outcomes for patients everywhere, especially those from underrepresented populations.

The advisory group is focused on addressing the industry’s most pressing operational challenges—from study startup and patient engagement to contracting and sustainability—through open dialogue and shared solutions. As part of this collaboration, hyperCORE will help:

• Strengthen industry awareness of site-level challenges related to feasibility, budgeting, and recruitment.

• Drive commercial accountability through strategic partnerships that de-risk study delivery, accelerate startup timelines, and enhance patient retention.

• Reduce study complexity by establishing clearer structures for metrics, oversight, and operational support.

• Optimize collaboration to streamline processes, eliminate recurring systemic barriers, and deliver more efficient, flexible trial execution.

This collective effort is dedicated to building a stronger, more sustainable clinical research ecosystem—one that is better aligned, better informed, and better equipped to bring lifesaving innovations to the patients who need them most.

At hyperCORE, we’re honored to contribute our experience, operational excellence, and unwavering commitment to quality as we join our peers in the strategic industry advisory group. Together, we’re not just envisioning the future of clinical research—we’re building it.